ATE555801T1 - Behandlung von endothelialer dysfunktion bei diabetes-patienten - Google Patents
Behandlung von endothelialer dysfunktion bei diabetes-patientenInfo
- Publication number
- ATE555801T1 ATE555801T1 AT07250870T AT07250870T ATE555801T1 AT E555801 T1 ATE555801 T1 AT E555801T1 AT 07250870 T AT07250870 T AT 07250870T AT 07250870 T AT07250870 T AT 07250870T AT E555801 T1 ATE555801 T1 AT E555801T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- endothelial dysfunction
- diabetes patients
- diabetes induced
- patient
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 4
- 206010048554 Endothelial dysfunction Diseases 0.000 title abstract 2
- 230000008694 endothelial dysfunction Effects 0.000 title abstract 2
- 102000015779 HDL Lipoproteins Human genes 0.000 abstract 2
- 108010010234 HDL Lipoproteins Proteins 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07250870A EP1964571B1 (de) | 2007-03-01 | 2007-03-01 | Behandlung von endothelialer Dysfunktion bei Diabetes-Patienten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555801T1 true ATE555801T1 (de) | 2012-05-15 |
Family
ID=38124002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07250870T ATE555801T1 (de) | 2007-03-01 | 2007-03-01 | Behandlung von endothelialer dysfunktion bei diabetes-patienten |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP1964571B1 (de) |
| AT (1) | ATE555801T1 (de) |
| DK (2) | DK2465519T3 (de) |
| ES (2) | ES2442594T3 (de) |
| PL (2) | PL1964571T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021204878A1 (en) * | 2020-04-08 | 2021-10-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cdon inhibitors for the treatment of endothelial dysfunction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6522486A (en) | 1985-10-04 | 1987-04-24 | Biotechnology Research Partners Limited | Recombinant apolipoproteins and methods |
| GB8625435D0 (en) | 1986-10-23 | 1986-11-26 | Erba Farmitalia | Human apolipoprotein ai |
| IT1229996B (it) | 1989-04-20 | 1991-09-20 | Cesare Sirtori | Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine. |
| US5652339A (en) | 1993-12-31 | 1997-07-29 | Rotkreuzstiftung Zentrallaboratorium | Method of producing reconstituted lipoproteins |
| SE9603303D0 (sv) | 1996-09-11 | 1996-09-11 | Pharmacia & Upjohn Ab | Process for purifying a protein |
| US6004925A (en) | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| US6037323A (en) | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| CN101189339A (zh) * | 2005-03-22 | 2008-05-28 | 美得思达健康有限公司 | 诊断和治疗心血管疾病的递送系统和方法 |
-
2007
- 2007-03-01 AT AT07250870T patent/ATE555801T1/de active
- 2007-03-01 DK DK11185508.6T patent/DK2465519T3/da active
- 2007-03-01 PL PL07250870T patent/PL1964571T3/pl unknown
- 2007-03-01 EP EP07250870A patent/EP1964571B1/de active Active
- 2007-03-01 EP EP11185508.6A patent/EP2465519B1/de active Active
- 2007-03-01 ES ES11185508.6T patent/ES2442594T3/es active Active
- 2007-03-01 DK DK07250870.8T patent/DK1964571T3/da active
- 2007-03-01 PL PL11185508T patent/PL2465519T3/pl unknown
- 2007-03-01 ES ES07250870T patent/ES2386905T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL1964571T3 (pl) | 2012-10-31 |
| EP2465519A1 (de) | 2012-06-20 |
| EP1964571A1 (de) | 2008-09-03 |
| PL2465519T3 (pl) | 2014-05-30 |
| DK1964571T3 (da) | 2012-08-13 |
| ES2386905T3 (es) | 2012-09-05 |
| ES2442594T3 (es) | 2014-02-12 |
| EP2465519B1 (de) | 2013-10-23 |
| DK2465519T3 (da) | 2014-02-03 |
| HK1171656A1 (en) | 2013-04-05 |
| EP1964571B1 (de) | 2012-05-02 |
| HK1121938A1 (en) | 2009-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE432693T1 (de) | Kombinationstherapie zur behandlung von diabetes und dadurch bedingten leiden sowie zur behandlung von mittels erhöhung des glp-1-spiegels im blut verbesserten leiden | |
| NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
| NZ592516A (en) | Antibodies to il-6 and use thereof | |
| MX2008013304A (es) | Compuestos de peptido 1 tipo glucagon. | |
| NO20082473L (no) | Fremgangsmater, sammensetninger og sett for behandling av medisinske tilstander | |
| NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
| EP1758597A4 (de) | Verwendung von arzneimittelkombinationen zur behandlung der insulinresistenz | |
| CY1115350T1 (el) | Χρησεις αναστολεων της dpp iv | |
| ATE407927T1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
| EA201001695A1 (ru) | Применение эпотилона d для лечения заболеваний, связанных с тау-белком | |
| EA201101568A1 (ru) | Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta | |
| ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
| IL192101A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels | |
| DE602007002625D1 (de) | Verwendung von botulintoxin zur linderung von hodenschmerzen | |
| EA201001749A1 (ru) | Способ лечения недифференцированного артрита | |
| CY1110620T1 (el) | Μεθοδος θεραπειας οξειας παραρρινοκολπιτιδας | |
| DE602005015841D1 (de) | Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes | |
| EA201071146A1 (ru) | Способы диагностирования, предупреждения и лечения болезней, связанных с костной массой | |
| EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
| BR0313588A (pt) | Métodos para o tratamento da demência com base em apo e genótipo | |
| UA101961C2 (xx) | Кристалічна форма 1 2-((r)-2-метилпіролідин-2-іл)-1h-бензімідазол-4-карбоксаміду$кристаллическая форма 1 2-((r)-2-метилпирролидин-2-ил)-1h-бензимидазол-4-карбоксамида | |
| ATE555801T1 (de) | Behandlung von endothelialer dysfunktion bei diabetes-patienten | |
| DK1771415T3 (da) | 2-(1H-indolylsulfanyl)-arylaminderivater til anvendelse i behandlingen af affektive sygdomme, smerte, ADHD og stressinkontinens | |
| ATE477820T1 (de) | Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten | |
| ATE468852T1 (de) | Lofexidine zur intraspinalen anwendung |